A Validated Automated THC Serum Method Still Had a Postmortem Limitation

A successful cannabinoid method validation does not establish suitability for every specimen. Researchers who developed an automated serum assay explicitly reported that postmortem samples could form a gel during extraction that the standard centrifugation procedure could not reliably separate.

What the automated method measured

The GC–MS workflow measured THC, 11-hydroxy-THC and free, unconjugated THC-COOH from 0.5 mL of serum. A robotic system handled extraction, phase separation, evaporation and derivatization-related steps, following initial sample and internal-standard preparation.

The authors compared manual and automated approaches using authentic forensic specimens and external controls. Both met the reported validation requirements, and the automated method successfully completed an external proficiency exercise.

The specimen problem occurred before chemical detection

Automation relies on predictable transfer of liquid between phases. Gel formation can disrupt that physical process, so a highly sensitive mass spectrometer cannot compensate simply by detecting smaller amounts.

The postmortem limitation concerned this particular automated workflow. It did not establish that all postmortem cannabinoid analysis is impossible, nor that every such specimen forms a gel. Another suitably validated preparation may address a specimen that this procedure cannot process reliably.

Agreement also varied across analytes

The manual–automated comparison used 20 real samples, although not every analyte was quantifiable in every sample. THC and THC-COOH results agreed more closely than 11-hydroxy-THC results, whose comparison showed greater deviations in the lower concentration range.

The method also checked carryover and potential interferences under defined conditions. Negative findings in those experiments support the tested workflow; they do not erase a separately identified specimen-handling limitation.

What to ask about an actual postmortem result

Identify the actual matrix, preparation method and validation scope. Ask whether unusual consistency, incomplete phase separation or other extraction problems were recorded, and how affected samples were handled.

Serum from living persons, postmortem serum and whole blood should not be treated as one interchangeable material. Nor does analytical validation itself establish that a measured concentration caused death or impairment. This paper illustrates why a method can perform well within its validated scope while requiring a different approach for a difficult specimen.

Related: Interpreting THC concentration and impairment.

Primary research

Development and validation of an automated liquid-liquid extraction GC/MS method for the determination of THC, 11-OH-THC, and free THC-carboxylic acid (THC-COOH) from blood serum. DOI: 10.1007/s00216-016-9537-5.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

CBD Epilepsy Trial Liver-Enzyme Events Often Involved Concomitant Valproate

Liver-enzyme events during CBD epilepsy trials often occurred in patients also taking valproate. That pattern makes the full medication regimen important, but it does not isolate which drug caused an individual event or establish safety without valproate. The finding came from treated epilepsy populations An original reanalysis of four randomized…

Spread the love

Read Article: CBD Epilepsy Trial Liver-Enzyme Events Often Involved Concomitant Valproate

Serum Cannabinoid Fingerprints Did Not Reliably Separate Medical and Street Cannabis

A broad serum cannabinoid panel did not reliably distinguish THC-rich medical cannabis from street cannabis in a pilot study. More analytes supplied useful patterns, but they did not create a universal test for prescription-source attribution. Different products were represented The study recruited 23 patients receiving cannabis-based medicines or medical cannabis…

Spread the love

Read Article: Serum Cannabinoid Fingerprints Did Not Reliably Separate Medical and Street Cannabis

Stored Cannabinoid Urine Screens Lost Signal Without Measuring Chemical Degradation

A stored urine specimen can lose cannabinoid screening response, but the response alone does not reveal exactly how much of a named compound chemically degraded. An analog-stability study used immunoassay signal as its endpoint rather than compound-specific mass-spectrometric concentrations. The experiment used fortified human urine Researchers added individual cannabinoid analogs…

Spread the love

Read Article: Stored Cannabinoid Urine Screens Lost Signal Without Measuring Chemical Degradation

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us